Priority Date: 12.05.11 (EP 20110165869)

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS

  • Application ID: EP12719993
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). CSL Behring GmbH is specialized in A61. CSL Behring GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 12.05.2011 - Priority Date (EP 20110165869)
  • 15.11.2012 - Publication A1 (WO2012152953)
  • 19.03.2014 - Publication A1 (EP2707005)
  • 23.08.2017 - Publication B1 (EP2707005)